We are live on !
Find out more
Harborview Advisors Portfolio holdings
AUM
$179M
Turnover
5.61%
1-Year Est. Return
23.7%
This Fund
S&P 500
This Quarter Est. Return
-1.77%
1 Year Est. Return
+23.7%
3 Year Est. Return
+27.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$179M
AUM Growth
-$88K
(-0.05%)
Cap. Flow
+$3.3M
Cap. Flow % of AUM
Cap. Flow %
1.85%
Top 10 Holdings %
Top 10 Hldgs %
53.45%
Holding
107
New
5
Increased
58
Reduced
30
Closed
1
Avg Time Held
2.3
years
Top 10 Avg Time Held
2.8
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Interest Rate Hedged Corporate Bond ETF
LQDH
|
+$984K |
| 2 |
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
|
+$415K |
| 3 |
Quest Diagnostics
DGX
|
+$337K |
| 4 |
Vanguard Morningstar Value ETF
VTV
|
+$296K |
| 5 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$228K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Value ETF
SCHV
|
+$303K |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$205K |
| 3 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$191K |
| 4 |
VanEck CEF Muni Income ETF
XMPT
|
+$96.3K |
| 5 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$95.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 95.34% |
| 2 | Technology | 1.77% |
| 3 | Healthcare | 1.39% |
| 4 | Communication Services | 0.54% |
| 5 | Consumer Discretionary | 0.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.91B
| $374K | 0.21% |
7,408
+158
| +2% | +$7.98K |
2021 Q1
2 quarters
|
|
77
Bristol-Myers Squibb
BMY
$129B
| $372K | 0.21% |
6,286
+5
| +0.1% | +$329 |
2019 Q2
9 quarters
|
|
78
PIMCO Enhanced Short Maturity Active ESG ETF
EMNT
$246M
| $369K | 0.21% |
3,670
-1
| -0% | -$101 |
2021 Q2
1 quarter
|
|
79
Pfizer
PFE
$173B
| $368K | 0.21% |
8,557
+1,006
| +13% | +$44.6K |
2019 Q3
8 quarters
|
|
80
Vanguard FTSE All-World ex-US ETF
VEU
$66.3B
| $364K | 0.2% |
5,972
-121
| -2% | -$7.61K |
2021 Q1
2 quarters
|
|
81
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.96B
| $363K | 0.2% |
2,185
+15
| +0.7% | +$2.56K |
2019 Q4
7 quarters
|
|
82
Invesco International Dividend Achievers ETF
PID
$893M
| $358K | 0.2% |
20,371
| – | – |
2019 Q1
10 quarters
|
|
|
83
Quest Diagnostics
DGX
$26.9B
| $335K | 0.19% |
+2,303
| New | +$337K |
2021 Q3
0 quarters
|
|
84
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $329K | 0.18% |
6,260
-70
| -1% | -$3.77K |
2017 Q4
15 quarters
|
|
85
CVS Health
CVS
$121B
| $321K | 0.18% |
3,778
+6
| +0.2% | +$503 |
2019 Q3
8 quarters
|
|
86
AT&T
T
$153B
| $321K | 0.18% |
15,753
+2,112
| +15% | +$44.4K |
2017 Q4
15 quarters
|
|
87
Johnson & Johnson
JNJ
$644B
| $306K | 0.17% |
1,897
| – | – |
2020 Q3
4 quarters
|
|
88
JPMorgan Chase
JPM
$894B
| $297K | 0.17% |
1,812
+3
| +0.2% | +$470 |
2020 Q4
3 quarters
|
|
89
Invesco Variable Rate Preferred ETF
VRP
$2.99B
| $293K | 0.16% |
11,186
+485
| +5% | +$12.8K |
2019 Q1
10 quarters
|
|
|
MGU
90
DELISTED
Macquarie Global Infrastructure Total Return Fund, Inc.
MGU
| $288K | 0.16% |
12,357
+315
| +3% | +$7.44K |
2021 Q1
2 quarters
|
|
91
Berkshire Hathaway Class B
BRK.B
$1.17T
| $286K | 0.16% |
1,048
+258
| +33% | +$72.5K |
2021 Q1
2 quarters
|
|
92
Vanguard Morningstar Growth ETF
VUG
$224B
| $282K | 0.16% |
5,826
| – | – |
2019 Q1
10 quarters
|
|
93
iShares Russell Mid-Cap Growth ETF
IWP
$18.7B
| $280K | 0.16% |
2,500
| – | – |
2020 Q2
5 quarters
|
|
94
Invesco Large Cap Value ETF
PWV
$1.86B
| $278K | 0.16% |
6,257
-35
| -0.6% | -$1.57K |
2019 Q1
10 quarters
|
|
95
Alphabet (Google) Class C
GOOG
$3.92T
| $267K | 0.15% |
2,000
| – | – |
2021 Q1
2 quarters
|
|
96
Schwab US REIT ETF
SCHH
$11B
| $262K | 0.15% |
11,486
+1,196
| +12% | +$28.5K |
2021 Q2
1 quarter
|
|
97
Global X Russell 2000 Covered Call ETF
RYLD
$1.29B
| $253K | 0.14% |
10,152
+704
| +7% | +$17.7K |
2020 Q3
4 quarters
|
|
98
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$12.6B
| $247K | 0.14% |
2,240
+127
| +6% | +$14.3K |
2021 Q2
1 quarter
|
|
99
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.27B
| $224K | 0.13% |
10,156
+663
| +7% | +$15K |
2020 Q4
3 quarters
|
|
100
Microsoft
MSFT
$3.87T
| $215K | 0.12% |
761
| – | – |
2021 Q2
1 quarter
|
|
Similar funds
DP
FWM
MCA
VAM
SCM
Harborview Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Harborview Advisors held 107 positions worth $179M, down 0.05% from $179M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Harborview Advisors's Q3 2021 filing shows 5 new, 58 increased, 30 reduced and 1 closed positions. Its largest new stake was Quest Diagnostics: 2,303 shares worth $335K. The largest sale was Schwab US Large-Cap Value ETF, an estimated $303K.
By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, down from 96% a quarter earlier, followed by Technology and Healthcare.
- Harborview Advisors's largest Q3 2021 buy was Quest Diagnostics: 2,303 shares worth $335K.
- Harborview Advisors added most to iShares Interest Rate Hedged Corporate Bond ETF in Q3 2021, an estimated $984K increase.
- Harborview Advisors's biggest Q3 2021 reduction was Schwab US Large-Cap Value ETF, cutting an estimated $303K.
- Harborview Advisors fully exited Vanguard FTSE Emerging Markets ETF in Q3 2021, selling an estimated $205K.
- Harborview Advisors's ten largest holdings make up 53% of its $179M portfolio in Q3 2021.
- Harborview Advisors opened 5 new positions and closed 1 in Q3 2021.
- Harborview Advisors's portfolio value fell 0.05% quarter-over-quarter to $179M.
Based on Harborview Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.